Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serotype-specific problems associated with pneumococcal conjugate vaccination.

William P Hanage1

  • 1Department of Infectious Disease Epidemiology, Imperial College London, Norfolk Place, London W2 1PG, UK. w.hanage@imperial.ac.uk.

Future Microbiology
|January 31, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Migration-linked TB epidemics: How TB elimination in high-income countries depends on the success of TB control in high-burden settings.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts.

The New England journal of medicine·2026
Same author

Bacterial-viral conflicts shape cholera evolution.

Nature·2026
Same author

Seasonal forcing and waning immunity drive the sub-annual periodicity of the COVID-19 epidemic.

PLoS pathogens·2026
Same author

The Potential Effect of Ending Centers for Disease Control and Prevention Funding for HIV Tests: A Modeling Study in 18 States.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Prediction of genetic relatedness of <i>Escherichia coli</i> using neighbor typing: a tool for rapid outbreak detection.

Antimicrobial agents and chemotherapy·2026
Same journal

Assessment of the enhanced antibacterial activity of snail mucus, thymol, and ferulic acid in a rat model of burn wounds infected with <i>Staphylococcus aureus</i> and <i>Pseudomonas aeruginosa</i>.

Future microbiology·2026
Same journal

Mechanistic insights into the inhibition of biofilm formation and antibacterial action of endophytic <i>Streptomyces</i> strain KJ7TB2 isolated from the Indian Sundarbans Mangrove estuary.

Future microbiology·2026
Same journal

Applications of lupeol to manage fungal infections: a promising multi-target molecule.

Future microbiology·2026
Same journal

Benzyl isothiocyanate-loaded chitosan beads: a novel strategy to combat biofilm formation by <i>Staphylococcus aureus</i> and <i>Escherichia coli</i>.

Future microbiology·2026
Same journal

<i>Mycobacterium colombiense</i> isolation among people living with human immunodeficiency virus: a case series.

Future microbiology·2026
Same journal

Thwarting the biothreat in the 21st century: means and methods.

Future microbiology·2026
See all related articles

Pneumococcal conjugate vaccines have reduced vaccine-type bacteria but led to replacement by non-vaccine types. This shift impacts disease patterns, especially in vulnerable groups, and informs future vaccination strategies.

Area of Science:

  • Infectious Diseases
  • Vaccinology
  • Microbial Ecology

Background:

  • A 2000 US-licensed pneumococcal conjugate vaccine targeted seven of 91 serotypes.
  • The vaccine significantly altered pneumococcal carriage and disease epidemiology.

Purpose of the Study:

  • To discuss the impact of serotype replacement on pneumococcal disease post-vaccination.
  • To identify key non-vaccine serotypes emerging in the post-vaccine era.
  • To examine consequences for vulnerable populations and other conditions.

Main Methods:

  • Review of epidemiological data and scientific literature on pneumococcal conjugate vaccine impact.
  • Analysis of serotype distribution changes in carriage and disease.
  • Assessment of vaccine impact on specific patient groups and disease manifestations.

Related Experiment Videos

Main Results:

  • Virtual elimination of vaccine serotypes from carriage.
  • Emergence and increased prevalence of non-vaccine serotypes.
  • Significant impact on disease incidence in vulnerable populations (e.g., Alaska Natives, HIV-infected individuals) and otitis media.

Conclusions:

  • Serotype replacement is a critical consequence of pneumococcal conjugate vaccination.
  • Non-vaccine serotypes pose an ongoing challenge, necessitating ongoing surveillance and potentially updated vaccines.
  • Lessons from the US experience are crucial for global conjugate vaccination strategies, particularly in resource-limited settings.